{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T10:11:46Z","timestamp":1777803106574,"version":"3.51.4"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":161,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Oxidative Medicine and Cellular Longevity"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p><jats:italic>Objective<\/jats:italic>. To compare the merits and demerits of PEG\u2010IFN<jats:italic>\u03b1<\/jats:italic>\u20102a and PEG\u2010IFN<jats:italic>\u03b1<\/jats:italic>\u20102b for the treatment of hepatitis B e antigen (HBeAg)\u2010positive chronic hepatitis B (CHB). <jats:italic>Methods<\/jats:italic>. Clinical files from eighty\u2010four CHB patients admitted to the Second Hospital of Shanxi Medical University between January 2018 and January 2019 were retrospectively analyzed and assigned to two groups: group 2a treated with PEG\u2010IFN<jats:italic>\u03b1<\/jats:italic>\u20102a and group 2b treated with PEG\u2010IFN<jats:italic>\u03b1<\/jats:italic>\u20102b. The clinical efficacy was compared between the above two arms, and the liver function (ALT, AST, HA, LN, and IV\u2010C), HBV\u2010DNA, HBsAg, HBeAg, and inflammatory factors (IFs, IL\u20101<jats:italic>\u03b2<\/jats:italic>, IL\u20106, IL\u20108, and TNF\u2010<jats:italic>\u03b1<\/jats:italic>) were tested at 12 weeks (T1), 24 weeks (T2), and 48 weeks (T3). The alterations of hemodynamics (SBP, DBP, MAP, and CVP), cardiac function (LVEF and BNP), and the incidence of adverse reactions (ARs) during treatment were recorded. Finally, the patients were followed up for 2 years to investigate the quality of life (QOL) as well as the positive seroconversion rate of HBsAg and HBeAg. <jats:italic>Results<\/jats:italic>. The overall response rate was similar in the two arms (<jats:italic>P<\/jats:italic> &gt; 0.05). After treatment, the liver function, HBV\u2010DNA, HBsAg, HBeAg, IFs, hemodynamics, and cardiac function were enormously improved (<jats:italic>P<\/jats:italic> &lt; 0.05), with faster improvement in group 2b compared with group 2a (<jats:italic>P<\/jats:italic> &lt; 0.05). The investigation of ARs identified notably lower incidence rates of alopecia, thrombocytopenia, and granulocytopenia in group 2a as compared to group 2b (<jats:italic>P<\/jats:italic> &lt; 0.05). The prognostic follow\u2010up results revealed no distinct difference in the QOL score and the positive seroconversion rate of HBsAg and HBeAg (<jats:italic>P<\/jats:italic> &gt; 0.05); however, the quantitative results of HBV\u2010DNA, HBsAg, and HBeAg in group 2b were lower than those in group 2a (<jats:italic>P<\/jats:italic> &lt; 0.05). <jats:italic>Conclusions<\/jats:italic>. Both PEG\u2010IFN<jats:italic>\u03b1<\/jats:italic>\u20102a and PEG\u2010IFN<jats:italic>\u03b1<\/jats:italic>\u20102b have excellent and stable therapeutic effects on HBeAg\u2010positive CHB, among which PEG\u2010IFN<jats:italic>\u03b1<\/jats:italic>\u20102b renders a faster treatment process but higher side effects, which can provide valuable references when choosing a treatment plan for CHB.<\/jats:p>","DOI":"10.1155\/2022\/3185320","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T19:35:42Z","timestamp":1654976142000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["[Retracted] Clinical Efficacy of PEG\u2010IFN\u03b1\u20102a and PEG\u2010IFN\u03b1\u20102b in the Treatment of Hepatitis B e Antigen\u2010Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4298-1436","authenticated-orcid":false,"given":"Nina","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biantao","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"e_1_2_8_1_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28280"},{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28156"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2018.06.002"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22881"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.06.008"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14369"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24270"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-019-09998-5"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2019.03.333"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12070741"},{"key":"e_1_2_8_11_2","first-page":"337","article-title":"Interferon-alfa in the treatment of chronic hepatitis B","volume":"3","author":"Zhang F.-K.","year":"2004","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328362389a"},{"key":"e_1_2_8_13_2","first-page":"1009","article-title":"Study on the relationship between hepatitis b virus genotypes and the effect of polyethylene glycol-interferon-alpha therapy on hbeag-positive chronic hepatitis B","volume":"52","author":"Gao G.","year":"2013","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22065"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1794769"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.4503"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes10040260"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12050515"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms161226087"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12790"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.08.008"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.39775"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206060"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5783-20"},{"key":"e_1_2_8_26_2","first-page":"365","article-title":"Changes and clinical significance of \u03b3\u03b4t cells in peripheral blood of patients with chronic hepatitis B during pegylated interferon \u03b1-2a treatment","volume":"26","author":"Liu K.","year":"2018","journal-title":"Zhonghua gan Zang Bing za zhi= Zhonghua Ganzangbing Zazhi= Chinese Journal of Hepatology"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00418.x"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep43752"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12833"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2018.09.005"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-001-0254-7"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12790"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2012.640671"}],"updated-by":[{"DOI":"10.1155\/2023\/9828565","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"record-id":"49797"},{"DOI":"10.1155\/2023\/9828565","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000}}],"container-title":["Oxidative Medicine and Cellular Longevity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/omcl\/2022\/3185320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/omcl\/2022\/3185320.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2022\/3185320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T23:40:00Z","timestamp":1748907600000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2022\/3185320"}},"subtitle":[],"editor":[{"given":"Shao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1155\/2022\/3185320"],"URL":"https:\/\/doi.org\/10.1155\/2022\/3185320","archive":["Portico"],"relation":{"retraction":[{"id-type":"doi","id":"10.1155\/2023\/9828565","asserted-by":"object"}]},"ISSN":["1942-0900","1942-0994"],"issn-type":[{"value":"1942-0900","type":"print"},{"value":"1942-0994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2022-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"3185320"}}